We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,672 results
  1. CTNNB1 Gene

    Daniela Furlan, Nora Sahnane in Endocrine Pathology
    Reference work entry 2022
  2. Alopecia areata-like pattern of baldness: the most recent update and the expansion of novel phenotype and genotype in the CTNNB1 gene

    Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) is a rare autosomal dominant genetic disorder caused by genetic...

    Aysan Moeinafshar, Sahand Tehrani Fateh, ... Mohammad-Reza Ghasemi in Neurological Sciences
    Article 28 June 2023
  3. Desmoplastic fibroma of the pediatric cranium with CTNNB1 mutation: case report and literature review

    Purpose

    Desmoplastic fibroma (DF) is an uncommon intermediate bone tumor rarely involving the skull with unidentified pathogenesis. We report the...

    **nyao Wang, Wenbin Guan, ... **aoqiang Wang in Child's Nervous System
    Article 18 April 2024
  4. Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression

    Background

    The catenin beta 1 gene (CTNNB1) plays a crucial role in the malignant progression of various cancers. Recent studies have suggested that...

    Tao Liu, Meng-Qi Fan, ... Shang-Ze Li in Journal of Translational Medicine
    Article Open access 22 September 2023
  5. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder

    Purpose

    We aimed to elucidate the underlying disease in a Hungarian family, with only one affected family member, a 16-year-old male Hungarian...

    Nikoletta Nagy, Margit Pál, ... Márta Széll in BMC Pediatrics
    Article Open access 15 January 2024
  6. Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability

    CTNNB1 encodes for the β-catenin protein, a component of the cadherin adhesion complex, which regulates cell–cell adhesion and gene expression in the...

    Sepide Dashti, Shadab Salehpour, ... Mohammad Miryounesi in Neurological Sciences
    Article 31 January 2022
  7. RUVBL1-modulated chromatin remodeling alters the transcriptional activity of oncogenic CTNNB1 in uveal melanoma

    Recent years have witnessed an increasing research interest in the therapeutic value of aberrant chromatin regulatory processes in carcinogenesis....

    Chao Zhang, Shuai Wu in Cell Death Discovery
    Article Open access 19 April 2023
  8. CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma

    CTNNB1 mutations play important roles in the development of soft tissue tumors, such as desmoid fibromatosis (DF), sinonasal tract angiofibroma,...

    Xuanxuan Zheng, **n He, ... Hongying Zhang in Virchows Archiv
    Article 06 January 2024
  9. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

    Background

    Catenin (Cadherin-Associated Protein), Beta 1 ( CTNNB1) genomic alterations are rare in prostate cancer (PCa). Gain-of-function mutations...

    Dilara Akhoundova, Stefanie Fischer, ... Mark A. Rubin in Diagnostic Pathology
    Article Open access 21 June 2024
  10. A Ctnnb1 enhancer regulates neocortical neurogenesis by controlling the abundance of intermediate progenitors

    β-catenin-dependent canonical Wnt signaling plays a plethora of roles in neocortex (Ncx) development, but its function in regulating the abundance of...

    Junbao Wang, Andi Wang, ... Yan Zhou in Cell Discovery
    Article Open access 02 August 2022
  11. Spastic Diplegia and Visual Defects in CTNNB1 Gene Mutation: Genetic Mimic of Cerebral Palsy

    Arushi Gahlot Saini, Pradeep Kumar Gunasekaran, ... Vikas Bhatia in Indian Journal of Pediatrics
    Article 08 November 2023
  12. SNHG1 functions as a ceRNA in hypertrophic scar fibroblast proliferation and apoptosis through miR-320b/CTNNB1 axis

    Hypertrophic scar (HS) is a fibrotic disease caused by skin injury. Competing endogenous RNA (ceRNA) has been demonstrated to implicate in the...

    Qiaoling Li, Bowei Zhang, ... Lei Zhang in Archives of Dermatological Research
    Article 09 February 2023
  13. m6A demethylase FTO regulate CTNNB1 to promote adipogenesis of chicken preadipocyte

    Background

    N6-methyladenosine (m 6 A) is an abundant post-transcriptional RNA modification that affects various biological processes. The fat mass and...

    Kan Li, Weichen Huang, ... Qinghua Nie in Journal of Animal Science and Biotechnology
    Article Open access 02 December 2022
  14. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA

    Bone metastasis is the most happened metastatic event in prostate cancer (PCa) and needs a large effort in treatment. When PCa metastasizes to the...

    Shouyi Zhang, Chengcheng Lv, ... Yu Zeng in Cell Death & Disease
    Article Open access 07 February 2023
  15. CTNNB1 polymorphism (rs121913407) in circulating tumor DNA (ctDNA) in Egyptian hepatocellular carcinoma patients

    Background

    Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide and the fourth in Egypt. Persistent inflammation and...

    Marwa A. Abdel-Wahed, Eman Mohamed Abdel Rahman Amer, ... Safeya Hamdy Zakaria Hassan in Egyptian Liver Journal
    Article Open access 20 July 2022
  16. Recurrent CTNNB1 mutations in craniofacial osteomas

    Osteoma is a benign bone forming tumor predominantly arising on the surface of craniofacial bones. While the vast majority of osteomas develops...

    Daniel Baumhoer, Ruth Berthold, ... Wolfgang Hartmann in Modern Pathology
    Article Open access 01 November 2021
  17. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report

    Background

    Most endometrial cancers are of low histological grade and uterine-confined, with a high 5-year survival rate. However, a small subset of...

    Lan Zhong, Wei Jiang, ... Liang Song in BMC Medical Genomics
    Article Open access 16 June 2023
  18. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing

    Background

    Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the...

    Juan He, Zhen Zeng, ... Yong Peng in Molecular Cancer
    Article Open access 18 December 2021
  19. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma

    Background

    Melanoma-intrinsic activated β-catenin pathway, the product of the catenin beta 1 ( CTNNB1) gene, has been associated with low/absent...

    Georgia Sofia Karachaliou, Rached Alkallas, ... Stergios J. Moschos in BMC Cancer
    Article Open access 05 January 2022
  20. CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence

    Background

    Hepatocellular carcinoma (HCC) is a fatal disease characterized by early genetic alterations in telomerase reverse transcriptase promoter...

    Filip Ambrozkiewicz, Andriy Trailin, ... Kari Hemminki in BMC Cancer
    Article Open access 13 August 2022
Did you find what you were looking for? Share feedback.